S100A8 and S100A9 Act As ‘primers’ of a Catabolic Response in Chondrocytes but Additional Signals Are Required to Activate Cartilage Degradation

A. van Hummel,C. Little,T. Vogl,J. Roth,H. Zreiqat

DOI: https://doi.org/10.1016/j.joca.2012.02.554

IF: 7.507

2012-01-01

Osteoarthritis and Cartilage

Abstract:Purpose: Calcium binding proteins S100A8 and S100A9 are increased in cartilage in acute and chronic inflammatory arthritis; however their role in osteoarthritis (OA) is less clear. Chondrocyte S100A8 and S100A9 mRNA are increased during the onset of surgically induced murine OA, but both are significantly downregulated as OA progresses. Interestingly, recent studies have shown that cartilage in S100A9-/- deficient mice is protected from degradation in joint instability accompanied by significant synovitis (collagenase-induced-) but not surgically-induced-OA. Whether this is due to more persistent expression of S100A8 and/or A9 or release of additional co-factors from the inflamed synovium in the collagenase model is unclear. S100A8 and S100A9, but not the heterodimer (S100A8/A9) rapidly induce MMP and ADAMTS mRNA expression in chondrocytes, but whether this leads to actual cartilage matrix breakdown has not been resolved. The aim of this study was to determine whether S100A8 or S100A9 alone or in combination with IL-1 can activate MMPs and aggrecanases with resultant chondrolysis and whether this is time-dependent. Methods: Normal ovine articular cartilage explants were cultured for 1, 2, 4, 7 or 14 days in serum-free media ± 10-7M human S100A8, S100A9 or S100A8/A9, with or without 10ng/ml IL-1α (n=6/treatment). Gene expression of S100A8, S100A9, key cartilage proteins, metalloproteinases and their inhibitors was measured using qRT-PCR. Collagen and aggrecan release were measured as hydroxyproline and glycosaminoglycan respectively. Media MMP-2 and MMP-9 activity were evaluated by gelatin zymography and MMP-13 using a fluorometric assay. Results: S100A8 and S100A9 alone significantly (p<0.05) up-regulated MMP1, MMP3, S100A9, ADAMTS5 and MMP13 mRNA throughout the time course of the experiment (ADAMTS5 and MMP13 were not regulated at day 14), whilst the heterodimer had little effect. Interestingly, S100A9 induced greater gene expression changes than S100A8 at days 1 and 2, whilst at later time points, S100A8 induced greater changes. While there were some temporal differences, IL-1α and the S100 monomers upregulated mRNA expression of a similar spectrum of MMPs and ADAMTSs. There were also no significant differences in gene expression between IL-1α treated explants with or without addition of the S100s. Strikingly, despite the pro-catabolic gene expression changes induced by stimulation with S100A8 or S100A9, this did not translate into increased pro or active MMP-2, -9 or-13, nor did it lead to an increase in aggrecan or collagen release at any time compared with control cultures. In contrast, IL-1α stimulated increased aggrecan release and active MMP-13 in media from day 2 onwards, as well as active MMP-2 from day 4. Conclusions: Taken together this data suggests that S100A8 and S100A9 may prime the cartilage for degradation through the upregulation of pro-enzymes, however a second co-factor appears to be needed in order to activate the system and induce actual cartilage degradation. The requirement for a co-stimulatory factor(s) is reminiscent of the need for both inflammasome assembly to activate caspase-1, in concert with the effect of pro-inflammatory stimuli (TLR activation or IL-1α/TNF), in order to get secretion of active IL-1β in the innate immune response. S100A8 and S100A9 are re cognised both as ligands for TLRs; and as damage associated molecular patterns (DAMPs), many of which can activate the inflammasome/caspase1. However, expression of TLR2/4 by chondrocytes is low in normal cartilage and upregulated in OA and/or by inflammatory cytokines. We could not demonstrate synergism between IL-1α and S100s; however this may reflect an already maximal response with the dose of IL-1α used in the present study. Ongoing studies will determine if sub-maximal doses of IL-1α or TNFα can enhance the chondrolytic activity of S100s through upregulation of TLRs.